Literature DB >> 7593322

The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein.

M Dundr1, G H Leno, M L Hammarskjöld, D Rekosh, C Helga-Maria, M O Olson.   

Abstract

The human immunodeficiency virus 1 (HIV-1) Rev transactivator protein plays a critical role in the regulation of expression of structural proteins by controlling the pathway of mRNA transport. The Rev protein is located predominantly in the nucleoli of HIV-1 infected or Rev-expressing cells. Previous studies demonstrated that the Rev protein forms a specific complex in vitro with protein B23 which is suggested to be a nucleolar receptor and/or carrier for the Rev protein. To study the role of the nucleolus and nucleolar proteins in Rev function, transfected COS-7 or transformed CMT3 cells expressing the Rev protein were examined for subcellular locations of Rev and other proteins using indirect immunofluorescence and immunoelectron microscopy. One day after transfection the Rev protein was found in most cells only in the nucleolar dense fibrillar and granular components where it colocalized with protein B23. These were designated class 1 cells. In a second class of cells Rev and B23 accumulated in the nucleoplasm as well as in nucleoli. Treatment of class 1 cells with actinomycin D (AMD) under conditions that blocked only RNA polymerase I transcription caused Rev to completely redistribute from nucleoli to the cytoplasm. Simultaneously, protein B23 was partially released from nucleoli, mostly into the nucleoplasm, with detectable amounts in the cytoplasm. In cells recovering from AMD treatment in the presence of cycloheximide Rev and B23 showed coincident relocation to nucleoli. Class 2 cells were resistant to AMD-induced Rev redistribution. Selective inhibition of RNA polymerase II transcription by alpha-amanitin or by DRB did not cause Rev to be released into the cytoplasm suggesting that active preribosomal RNA transcription is required for the nucleolar location of Rev. However, treatment with either of the latter two drugs at higher doses and for longer times caused partial disruption of nucleoli accompanied by translocation of the Rev protein to the cytoplasm. These results suggest that the nucleolar location of Rev depends on continuous preribosomal RNA transcription and a substantially intact nucleolar structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593322     DOI: 10.1242/jcs.108.8.2811

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  48 in total

1.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.

Authors:  S B Buonomo; A Michienzi; F G De Angelis; I Bozzoni
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

2.  Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm.

Authors:  D A Matthews
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  A nucleolar TAR decoy inhibitor of HIV-1 replication.

Authors:  Alessandro Michienzi; Shirley Li; John A Zaia; John J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

4.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Identification of a small, very acidic constitutive nucleolar protein (NO29) as a member of the nucleoplasmin family.

Authors:  R F Zirwes; M S Schmidt-Zachmann; W W Franke
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

6.  Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication.

Authors:  Wen-Hung Huang; Yen-Shun Chen; Pei-Jer Chen
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  Nucleolar translocalization of GRA10 of Toxoplasma gondii transfectionally expressed in HeLa cells.

Authors:  Hye-Jin Ahn; Sehra Kim; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2007-09       Impact factor: 1.341

8.  Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.

Authors:  Dusan Cmarko; Stig-Ove Bøe; Catia Scassellati; Anne Marie Szilvay; Svend Davanger; Xiang-Dong Fu; Gunnar Haukenes; Karl-Henning Kalland; Stanislav Fakan
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.

Authors:  S F Ding; J Noronha; S Joshi
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

10.  Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec.

Authors:  Alessia Ruggieri; Esther Maldener; Marlies Sauter; Nikolaus Mueller-Lantzsch; Eckart Meese; Oliver T Fackler; Jens Mayer
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.